Preserving Effective Tuberculosis Treatment Study in Peru

In accordance with FAR subpart 13.106-1(b), the Centers for Disease Control and Prevention (CDC) intends to issue a sole source purchase order to the Partners in Health, in Boston, MA. The purpose of this purchase order is to support the completion and evaluation of projects initiated under the partnership with PIH and the Division of Tuberculosis Elimination (DBTE). The activities will focus on comparing the frequency of acquired resistance to second line anti-TB drugs among MDR TB patients in GLC versus non-GLC sites who are being treated with 2nd-line anti-TB drugs; to determine the risk factors for acquired resistance in these same groups; and to determine and compare MDR TB treatment success rates in these same groups. At present, all project records and data are maintained by the PIH and its subsidiary. Interested parties who feel that they possess the capabilities to provide the services described above should submit a capability statement demonstrating their abilities to provide the services. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive requirement. Please send your documentation to Sheila Dolan at the office identified above, by fax (770) 488-2688, or email to egy8@cdc.gov. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract, based upon responses to this notification, is solely within discretion of the government.